HER-2 NEGATIVE BREAST CANCER MARKET ANALYSIS

HER-2 Negative Breast Cancer Market, By Type of Treatment (Chemotherapy, Radiation, Hormonal Therapy, and Other Types of Treatments) and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : Mar 2023
Code : CMI5622
Pages :171
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global HER-2 Negative Breast Cancer Market: Key Companies Insights

The global HER-2 negative breast cancer market is highly competitive. This is attributed to the rise in burden of HER-2 negative breast cancer worldwide, as a result, players in the market are focusing on launching novel products in the market. Some of the key players in the global HER-2 negative breast cancer market are Pfizer Inc., Novartis AG, Merck & Co. Inc., GSK PLC, AstraZeneca, Eli Lilly and Company, and Bristol-Myers Squibb Company (Celgene Corporation), among others.